Background and Purpose: Epimedii Folium is a traditional herb
widely-utilized in China. Recently, our study discovered that Epimedin B
(EB), as a high-content, low-toxicity flavonoid compound in Epimedii
Folium extract, strongly showed melanogenesis and tyrosinase activation
effect. However, there are no studies of EB in pigment synthesis and
regulation mechanism. This study aims to evaluate the pigmentation
effect of EB and elucidate the melanogenic mechanism. Experimental
Approach: Melanin contents in melanoma cells, primary human melanocytes,
human skin tissues, and intracellular melanosomes changes were
determined to evaluate the melanogenic effect of EB. The influence of
TYRs expression was determined by RNA sequencing and mRNA/proteins
changes. The tyrosinase activity were tested on mushroom tyrosinase,
depigmented models of melanoma cells, zebrafishes and C57BL/6 mice. The
stability of TYRs were investigated by monobenzone-induced TYRs
degradation on melanoma cells, skin tissues and C57BL/6 mice, analyzed
by cellular ubiquitin, chaperone co-expression, and endoplasmic
reticulum/ proteasome co-localization assays. Key Results: EB increased
TYRs expression through MITF-mediated pathways, then to promote
melanosome number and maturation for melanogenesis. Additionally, EB
exerted repigmentation through activating tyrosinase activity in
multiple tyrosinase inhibitive models. Furthermore, EB could protect
monobenzone-induced TYRs degradation and repigmentation in vitro and in
vivo, enhance TYRs stability via inhibiting misfolded tyrosinase,
TYR-related protein 1 formation, retention in endoplasmic reticulum, and
ubiquitin-proteasome system. Conclusion and Implications: These data
conclude that EB can target TYRs from expression, catalytic activity and
stability approaches to exhibit pigmentation function, which might
provide a novel rational strategy for hypopigmentation in pharmaceutical
and cosmetic industries.